{"id":"W2161723853","doi":"10.1111/apt.13001","title":"A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Atlantic Healthcare; Relypsa; Astellas Pharma; ActoGeniX; Shire; Bristol-Myers Squibb; Eli Lilly and Company; Orexigen Therapeutics; Biogen; Celgene; Therakos; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Takeda Oncology; Tillotts Pharma; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Receiver operating characteristic; Crohn's disease; Internal medicine; Disease; Abdominal pain; Methotrexate; Physical therapy; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000713501,0.0001940376,0.0002486749,0.00005198302,0.0002126868,0.000007240523,0.0003139058,0.00006198343,0.00002756795],"category_scores_gemma":[0.00000325458,0.0001248264,0.0002843737,0.0001354673,0.0002473273,0.000005343909,0.0001274042,0.000102016,3.135307e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005412767,"about_ca_system_score_gemma":0.0002295662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006403677,"about_ca_topic_score_gemma":0.00003821271,"domain_scores_codex":[0.9983748,0.0003212829,0.0005096428,0.0003028129,0.0002643207,0.0002271555],"domain_scores_gemma":[0.998618,0.00008814163,0.0005071166,0.0004933335,0.0002222273,0.00007116351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002577675,0.0008674347,0.607972,0.00005562899,0.06380913,0.000009455883,0.0005598565,0.002221915,0.3191901,0.00008847548,0.0001385292,0.002509822],"study_design_scores_gemma":[0.0008341035,0.0001420956,0.8946171,0.000002587149,0.01713423,5.251099e-7,0.0001031803,0.00168318,0.08319133,0.00003802867,0.002110749,0.0001428589],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917882,0.0001932876,0.006243261,0.0005088294,0.0002706106,0.0008943958,0.00005608879,0.000008080126,0.00003721027],"genre_scores_gemma":[0.9970364,0.00003550795,0.0006432846,0.001871316,0.00006834231,0.0002506592,0.00005234771,0.00001869009,0.00002343674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2866451,"threshold_uncertainty_score":0.5090275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03300852250896508,"score_gpt":0.343035266853021,"score_spread":0.310026744344056,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}